布地奈德对嗜中性粒细胞性鼻息肉中CD8+CD25+Foxp3+Treg细胞的作用

蔺林, 戴飞, 魏瑾瑾, 等. 布地奈德对嗜中性粒细胞性鼻息肉中CD8+CD25+Foxp3+Treg细胞的作用[J]. 临床耳鼻咽喉头颈外科杂志, 2020, 34(8): 701-705. doi: 10.13201/j.issn.2096-7993.2020.08.006
引用本文: 蔺林, 戴飞, 魏瑾瑾, 等. 布地奈德对嗜中性粒细胞性鼻息肉中CD8+CD25+Foxp3+Treg细胞的作用[J]. 临床耳鼻咽喉头颈外科杂志, 2020, 34(8): 701-705. doi: 10.13201/j.issn.2096-7993.2020.08.006
LIN Lin, DAI Fei, WEI Jinjin, et al. The role of budesonide on CD8+CD25+Foxp3+ Treg cells in neutrophilic nasal polyps[J]. J Clin Otorhinolaryngol Head Neck Surg, 2020, 34(8): 701-705. doi: 10.13201/j.issn.2096-7993.2020.08.006
Citation: LIN Lin, DAI Fei, WEI Jinjin, et al. The role of budesonide on CD8+CD25+Foxp3+ Treg cells in neutrophilic nasal polyps[J]. J Clin Otorhinolaryngol Head Neck Surg, 2020, 34(8): 701-705. doi: 10.13201/j.issn.2096-7993.2020.08.006

布地奈德对嗜中性粒细胞性鼻息肉中CD8+CD25+Foxp3+Treg细胞的作用

详细信息

The role of budesonide on CD8+CD25+Foxp3+ Treg cells in neutrophilic nasal polyps

More Information
  • 目的  探讨布地奈德对CD8+CD25+Foxp3+Treg细胞的影响,并评估其在嗜中性粒细胞性鼻息肉(NP)中的作用。 方法  招募8例嗜中性粒细胞性CRSwNP患者,并予以布地奈德鼻喷剂治疗3个月。分别从正常鼻黏膜组织和NP中获取样本,进行体外培养,分别从正常鼻黏膜组织和NP中分离和提纯CD8+CD25+Foxp3+Treg细胞,也进行体外培养。随后检测该Treg细胞培养液中转化生长因子-β(TGF-β)及其mRNA的含量。将体外培养的CD8+CD25+Foxp3+Treg细胞加入NP培养液中,并对该组织培养液中髓过氧化物酶(MPO)和IFN-γ的浓度进行检测。 结果  NP中CD8+CD25+Foxp3+Treg细胞所占CD8+T细胞的百分比较正常黏膜组织有所降低,而布地奈德喷鼻治疗并未升高该Treg细胞的百分比,TGF-β及其mRNA在该细胞培养液中的浓度高于正常黏膜组织来源的Treg细胞,CD8+CD25+Foxp3+Treg细胞干预体外培养的NP后,组织培养液中MPO和IFN-γ的浓度较干预前降低。 结论  CD8+CD25+Foxp3+Treg细胞可以调节嗜中性粒细胞性NP中的炎症反应,而布地奈德的治疗对该细胞的作用有限。
  • 加载中
  • 图 1  正常鼻黏膜和鼻息肉组织的免疫荧光染色

    图 2  治疗前和治疗后CD8+CD25+Foxp3+Treg细胞流式细胞仪检测

    图 3  治疗前和治疗后培养液中TGF-β浓度的比较

    图 4  治疗前和治疗后培养液中MPO和IFN-γ浓度的比较

  • [1]

    Soyka MB, Wawrzyniak P, Eiwegger T, et al. Defective epithelial barrier in chronic rhinosinusitis: The regulation of tight junctions by IFN-gamma and IL-4[J]. J Allergy Clin Immunol, 2012, 130(5): 1087-1096. e10. doi: 10.1016/j.jaci.2012.05.052

    [2]

    Fokkens WJ, Lund VJ, Mullol J, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012[J]. Rhinol Suppl, 2012, 23: 3p preceding table of contents: 1-298.

    [3]

    Jankowski R, Bouchoua F, Coffinet L, et al. Clinical factors influencing the eosinophil infiltration of nasal polyps[J]. Rhinology, 2002, 40(4): 173-178.

    [4]

    Zhang N, Van Zele T, Perez-Novo C, et al. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease[J]. J Allergy Clin Immunol, 2008, 122(5): 961-968. doi: 10.1016/j.jaci.2008.07.008

    [5]

    Wing K, Sakaguchi S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity[J]. Nat Immunol, 2010, 11(1): 7-13. doi: 10.1038/ni.1818

    [6]

    Robb RJ, Lineburg KE, Kuns RD, et al. Identification and expansion of highly suppressive CD8(+)FoxP3(+)regulatory T cells after experimental allogeneic bone marrow transplantation[J]. Blood, 2012, 119(24): 5898-5908. doi: 10.1182/blood-2011-12-396119

    [7]

    Vaidyanathan S, Barnes M, Williamson P, et al. Treatment of chronic rhinosinusitis with nasal polyposis with oral steroids followed by topical steroids: a randomized trial[J]. Ann Intern Med, 2011, 154(5): 293-302. doi: 10.7326/0003-4819-154-5-201103010-00003

    [8]

    Wen W, Liu W, Zhang L, et al. Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy[J]. J Allergy Clin Immunol, 2012, 129(6): 1522-1528. e5. doi: 10.1016/j.jaci.2012.01.079

    [9]

    中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 中国慢性鼻窦炎诊断和治疗指南(2018)[J]. 中华耳鼻咽喉头颈外科杂志, 2019, 54(1): 81-100.

    [10]

    Park SK, Lee WJ, Yang YI. Organ culture at the air-liquid interface maintains structural and functional integrities of inflammatory and fibrovascular cells of nasal polyps[J]. Am J Rhinol, 2007, 21(4): 402-407. doi: 10.2500/ajr.2007.21.3050

    [11]

    Ho J, Bailey M, Zaunders J, et al. Group 2 innate lymphoid cells(ILC2s)are increased in chronic rhinosinusitis with nasal polyps or eosinophilia[J]. Clin Exp Allergy, 2015, 45(2): 394-403. doi: 10.1111/cea.12462

    [12]

    Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: Establishing definitions for clinical research and patient care[J]. J Allergy Clin Immunol, 2004, 114(6): 155-212. doi: 10.1016/j.jaci.2004.09.029

    [13]

    Cao PP, Li HB, Wang BF, et al. Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese[J]. J Allergy Clin Immunol, 2009, 124(3): 478-484, 484. e1-2. doi: 10.1016/j.jaci.2009.05.017

    [14]

    Hissaria P, Smith W, Wormald PJ, et al. Short course of systemic corticosteroids in sinonasal polyposis: a double-blind, randomized, placebo-controlled trial with evaluation of outcome measures[J]. J Allergy Clin Immunol, 2006, 118(1): 128-133. doi: 10.1016/j.jaci.2006.03.012

    [15]

    Peric A, Vojvodic D, Matkovic-Jozin S. Effect of long-term, low-dose clarithromycin on T helper 2 cytokines, eosinophilic cationic protein and the'regulatedon activation, normal T cell expressed and secreted' chemokine in the nasal secretions of patients with nasal polyposis[J]. J Laryngol Otol, 2012, 126(5): 495-502. doi: 10.1017/S0022215112000485

    [16]

    Gershon RK, Kondo K. Cell interactions in the induction of tolerance: the role of thymic lymphocytes[J]. Immunology, 1970, 18(5): 723-737.

    [17]

    Cosmi L, Liotta F, Lazzeri E, et al. Human CD8+CD25+thymocytes share phenotypic and functional features with CD4+CD25+regulatory thymocytes[J]. Blood, 2003, 102(12): 4107-4114. doi: 10.1182/blood-2003-04-1320

    [18]

    Kiniwa Y, Miyahara Y, Wang HY, et al. CD8+Foxp3+regulatory T cells mediate immunosuppression in prostate cancer[J]. Clin Cancer Res, 2007, 13(23): 6947-6958. doi: 10.1158/1078-0432.CCR-07-0842

    [19]

    Pant H, Hughes A, Schembri M, et al. CD4+and CD8+regulatory T cells in chronic rhinosinusitis mucosa[J]. Am J Rhinol Allergy, 2014, 28(2): 83-89. doi: 10.2500/ajra.2013.28.4014

  • 加载中

(4)

计量
  • 文章访问数:  1143
  • PDF下载数:  331
  • 施引文献:  0
出版历程
收稿日期:  2020-02-08
刊出日期:  2020-08-05

目录